Given its effectiveness, its no surprise that prescriptions for Ozempic have increased by 857% since 2019
In May 2025, Illumina, Inc., and Ovation.io, Inc., announced the development of the largest commercially available clinical multiomic dataset from 25,000 patients treated with glucagon-like peptide-1 (GLP-1) receptor agonist therapies
The worlds largest trade group representing airlines expects the oil spike to halve profits by 49% from last year to $23 billion
Until official regulatory approval is granted, there is no approved maximum dose for clinical use
Discovery of novel 5,6-Dihydro-1,2,4-triazine derivatives as efficacious glucagon-like peptide-1 receptor agonists
Patients benefit from round-the-clock support, individualized treatment plans, and a focus on long-term wellness, not just symptom control